Jane A. Gross
Independent DirectorDr. Jane A. Gross, Ph.D. is Member of Scientific Advisory Board at Amberstone Biosciences, Inc. since 2024. She served as Chief Scientific Officer at Aptevo Therapeutics Inc. since 2022. She serves as an Independent Director at BriaCell Therapeutics Corp. since January 18, 2022. She is Independent Director of BriaPro Therapeutics Corp. from 2023. She is a highly experienced biotech executive with leading research and development teams. She serves as Chief Scientific Officer & Executive Officer since September 14, 2021 at Aptevo Therapeutics Inc. and served as its Senior Vice President of Research and Development since September 2016 until September 14, 2021. Dr. Gross serves as an Independent Director of aTyr Pharma, Inc. since June 2019. Dr. Gross served as Vice President of Applied Research and Non-Clinical Development at Aptevo Therapeutics Inc. (Also known as Emergent Biosolutions Inc.) from July 2016 to September 2016. Dr. Gross continues to lead research and non-clinical development, a position she has held at Emergent. She leads research efforts in molecular biology and protein engineering, immunology, protein and cell sciences and translational research for clinical development. She has experience in the discovery and development of novel protein therapeutics in autoimmune, infectious disease and oncology indications and is an inventor on over 100 patents. Prior to joining Emergent, she served as Vice President of Immunology Research at ZymoGenetics Inc. where she led efforts in discovery and development of therapeutics from novel genes for treatment of AIID and cancer. She served as a Trustee of Bloodworks Northwest until July 2015. She served as a Trustee of Puget Sound Blood Center and Program. Dr. Gross holds Ph.D. in Immunology from University of California at Berkeley and a Post-Doctoral Fellowship from the University of Washington in Immunology.
Positions
- Company NameaTyr Pharma, Inc.Stock CodeATYRPositionIndependent DirectorColleagues
- SSSanjay S. ShuklaPresident, CEO & Director
- TPTimothy P. CoughlinIndependent Chairman of the Board
- BYBrandon YarasChief Financial Officer
- ADAshlee DunstonDirector of Investor Relations & Corporate Communications
- DCDanielle CampbellVP of Human Resource
- LNLeslie NangleVice President of Research
- SLSvetlana LucasIndependent Director
- SLSara L. ZaknoenIndependent Director
